CPT code 11921 represents medical tattooing (permanent camouflage) of a localized skin defect measuring 6.1 to 20.0 cm² using intradermal insoluble opaque pigments. This procedure addresses pigmentary abnormalities arising from congenital conditions, burns, vitiligo, birthmarks, and post-reconstructive needs such as nipple-areola complex restoration after breast reconstruction. Nationally, the code matters because it defines a discrete, billable service that intersects dermatology, plastic and reconstructive surgery, and cosmetic restoration care, with implications for clinical documentation, coverage determinations, and outpatient procedural billing.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for using 11921, typical settings where the service is delivered, and what payers commonly consider when adjudicating claims for medical tattooing. The report summarizes benchmarks and coverage considerations, highlights common billing modifiers and claim line practices, and outlines areas where coding clarity and consistent documentation influence reimbursement outcomes. Where input data is missing, the publication notes that those specific details are not available in the source material. The content is written for a national audience and is intended to support coding, billing, and policy professionals in understanding the scope and use of CPT code 11921.